Trademark: 88788692
Status Date
Wednesday, January 17, 2024
Filing Date
Friday, February 7, 2020
5 Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant
42 Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
Jan 17, 2024
Report Completed Suspension Check Case Still Suspended
Jun 15, 2023
Report Completed Suspension Check Case Still Suspended
Nov 30, 2022
Report Completed Suspension Check Case Still Suspended
Apr 27, 2022
Report Completed Suspension Check Case Still Suspended
Aug 20, 2021
Report Completed Suspension Check Case Still Suspended
Nov 27, 2020
Notification Of Letter Of Suspension E-Mailed
Nov 27, 2020
Letter Of Suspension E-Mailed
Nov 27, 2020
Suspension Letter Written
Nov 5, 2020
Teas/Email Correspondence Entered
Nov 4, 2020
Correspondence Received In Law Office
Nov 4, 2020
Teas Response To Office Action Received
May 4, 2020
Notification Of Non-Final Action E-Mailed
May 4, 2020
Non-Final Action E-Mailed
May 4, 2020
Non-Final Action Written
Apr 28, 2020
Assigned To Examiner
Feb 11, 2020
New Application Office Supplied Data Entered
Feb 11, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
